C. Lin, “Clinical Evaluation of Bexagliflozin and Other SGLT2 Inhibitors for Type 2 Diabetes Management”, HSET, vol. 74, pp. 1576–1580, Dec. 2023, doi: 10.54097/zzqmbq95.